Bayer’s Incoming CEO Faces Consumer Health Decision
Activist investors are pushing for a break-up of Bayer's conglomerate structure and the sale of its Consumer Health division. It will be up to incoming CEO Bill Anderson to make the call.
Activist investors are pushing for a break-up of Bayer's conglomerate structure and the sale of its Consumer Health division. It will be up to incoming CEO Bill Anderson to make the call.